BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17711430)

  • 1. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
    Gehi A; Benatar M; Langberg J
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma.
    Gajra A; Vajpayee N; Grethlein SJ
    Am J Hematol; 2004 Oct; 77(2):196-7. PubMed ID: 15389902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine.
    Khan MS; Tiwari A; Khan Z; Sharma H; Taleb M; Hammersley J
    Case Rep Cardiol; 2017; 2017():6956298. PubMed ID: 28589042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridostigmine Suicidal Attempt in a Myasthenia Gravis Patient.
    Malabaey MAT; Al-Saud AA; Alaska YA; Almas A; Malik A
    Am J Case Rep; 2019 Sep; 20():1418-1421. PubMed ID: 31554781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disopyramide for transient high-degree atrioventricular block in a young patient with a history of syncope.
    Hirai Y; Yamamoto H; Nakano Y; Ogi H; Kajiwara S; Kohno N
    J Cardiol; 2008 Aug; 52(1):59-61. PubMed ID: 18639779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal myasthenia gravis: report of 40 cases.
    Mao VH; Abaza M; Spiegel JR; Mandel S; Hawkshaw M; Heuer RJ; Sataloff RT
    J Voice; 2001 Mar; 15(1):122-30. PubMed ID: 12269627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis.
    Punga AR; Sawada M; Stålberg EV
    Muscle Nerve; 2008 Mar; 37(3):300-7. PubMed ID: 18069667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pro-arrhythmia effect of pyridostigmine. Apropos of a case].
    Leenhardt A; Thomas O; Haouala H; Benaïm R; Maison-Blanche P; Cauchemez B; Haguenau M; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1992 Dec; 85(12):1853-6. PubMed ID: 1306628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthesia and myasthenia gravis.
    Blichfeldt-Lauridsen L; Hansen BD
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):17-22. PubMed ID: 22091897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asystole during electroconvulsive therapy in a patient with depression and myasthenia gravis].
    Otsuka H; Shikama H; Saito T; Ishikawa T; Kemmotsu O
    Masui; 2000 Aug; 49(8):893-5. PubMed ID: 10998885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridostigmine-induced high grade SA-block in a patient with myasthenia gravis.
    Said S; Cooper CJ; Alkhateeb H; Elhanafi S; Bizet J; Gosavi S; Abedin Z
    Am J Case Rep; 2013; 14():359-61. PubMed ID: 24046803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis accompanied with hypokalemic periodic paralysis.
    Sawanyawisuth K; Tiamkao S; Pratipanawatr T
    J Med Assoc Thai; 2006 May; 89(5):727-9. PubMed ID: 16756062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis.
    Voon YC; Yahya WN; Hasan S; Ibrahim NM
    Mov Disord; 2010 Jul; 25(9):1299-300. PubMed ID: 20629121
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical therapy for oropharyngeal symptoms of myasthenia gravis.
    Dooley JM; Goulden KJ; Gatien JG; Gibson EJ; Brown BS
    Ann Neurol; 1986 Feb; 19(2):192-4. PubMed ID: 3963762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
    Roberts DV; Taylor K; Wilson A
    J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune myasthenia gravis in a ferret.
    Couturier J; Huynh M; Boussarie D; Cauzinille L; Shelton GD
    J Am Vet Med Assoc; 2009 Dec; 235(12):1462-6. PubMed ID: 20001782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.